Science

Hondius Andes Outbreak: Diagnostic Challenges Persist Amid Hantavirus Response

Testing complexities for the MV Hondius Andes hantavirus outbreak highlight the critical balance between rapid detection and accurate diagnosis, particularly concerning cross-reactivity and regional lab capacities. Officials continue to refine protocols.

HCD

Hantavirus Cruise Desk

Outbreak Tracking Team · September 9, 2026 · 6 min read

Hondius Andes Outbreak: Diagnostic Challenges Persist Amid Hantavirus Response

Diagnostic Hurdles Shape Hantavirus Response Off Cape Verde

PRAIA, Cape Verde – The ongoing hantavirus outbreak associated with the MV Hondius Andes, anchored off Praia since May 2026, continues to underscore bigly diagnostic challenges, particularly on the accurate and timely identification of cases. The interplay between molecular (RT-PCR) and serological testing methods, coupled with concerns about cross-reactivity and the regional laboratory capacity in West Africa, remains a central focus for public health authorities.

RT-PCR vs. Serology: A Timely Dilemma

Real-time reverse transcription polymerase chain reaction (RT-PCR) tests are crucial for detecting the genetic material of the hantavirus early in the infection, often within the first few days of symptom onset. This method provides direct evidence of active viral replication. Yet, its window of detection is finite; as the immune system mounts a response, viral load can decrease, making RT-PCR less effective later in the disease course. For the MV Hondius Andes situation, initial screening of symptomatic individuals has heavily relied on RT-PCR to identify acute infections and inform immediate isolation and contact tracing efforts. Conversely, serological tests, which detect antibodies (IgM and IgG) produced by the body in response to infection, offer a broader diagnostic window. IgM antibodies typically appear within one to two weeks of symptom onset and can persist for several weeks to months, indicating a recent infection. IgG antibodies, which develop later, usually signal past exposure and immunity. Serology is invaluable for confirming suspected cases where RT-PCR might be negative due to delayed testing or advanced disease stages. It too plays a critical role in epidemiological investigations to understand the extent of exposure within a population, including asymptomatic or mild cases not captured by RT-PCR screening. Public health officials, including those from the World Health Organization (WHO) and Africa Centres for Disease Control and Prevention (Africa CDC), have emphasized the need for a combined approach. For individuals presenting with acute symptoms, an initial RT-PCR test is recommended. If negative yet clinical suspicion remains high, or if symptoms have been present for more than a week, serological testing for IgM antibodies is advised. This sequential or parallel testing strategy aims to maximize detection rates across the varying stages of infection.

Cross-Reactivity Concerns

A bigly hurdle in hantavirus serodiagnostics is the potential for cross-reactivity with antibodies produced in response to other viral infections, particularly those caused by other hantavirus species or even unrelated viruses.Hantaviruses are a diverse group. While the specific strain or strains involved in the MV Hondius Andes outbreak have been subject to ongoing genetic sequencing efforts, regional exposure to other rodent-borne pathogens could complicate serological interpretation. Cross-reactivity can lead to false-positive results, potentially misclassifying individuals as having been exposed to the outbreak hantavirus when they have not. This issue is particularly pertinent in regions where different hantavirus species circulate endemically or where other febrile illnesses are common.Public health agencies are working to mitigate this by utilizing highly specific diagnostic kits where available. By implementing confirmatory testing protocols, potentially involving Western blot assays or paired acute and convalescent sera samples, to resolve ambiguous results. As of late August 2026, per reports from the US Centers for Disease Control and Prevention (US CDC) and the European Centre for Disease Prevention and Control (ECDC), laboratories involved in the MV Hondius Andes response are actively working to characterize the specific hantavirus genotype. This genomic information is vital for developing and validating more targeted and less cross-reactive diagnostic assays moving forward.

Laboratory Capacity in West Africa

The diagnostic effort for the MV Hondius Andes outbreak has stretched regional laboratory capacities. While major reference laboratories, often supported by international partners, possess the equipment and expertise for RT-PCR and advanced serological testing, the sheer volume of samples from the vessel and its contacts presents an logistical challenge. Before the outbreak, hantavirus testing was not a routine diagnostic procedure in many West African nations, requiring rapid establishment of protocols and training for staff. Efforts by WHO and Africa CDC have focused on bolstering in-country diagnostic capabilities in Cape Verde and surrounding nations. This includes the provision of testing reagents, equipment, and expert technical support.Establishing strong cold chains for sample transportation, ensuring quality control for testing procedures. Training local personnel in biosafety for handling hantavirus samples are critical components of this capacity-building initiative. The long-term goal is to enhance regional preparedness for emerging zoonotic threats, moving beyond the immediate crisis response. Behind the scenes: the international nature of the MV Hondius Andes outbreak, involving passengers and crew from multiple countries, has too necessitated coordination among national public health laboratories across continents. This collaborative network ensures that diagnostic results are shared efficiently and consistently, informing global epidemiological assessments and response strategies.

Evolving Protocols and Future Outlook

The diagnostic protocols for the MV Hondius Andes outbreak remain dynamic, adapting to new scientific insights and logistical realities. The experience gained is expected to inform future guidelines for hantavirus surveillance and outbreak management, particularly in regions where these viruses are not endemic but where imported cases pose a risk. Public health authorities continue to monitor the situation closely, emphasizing the importance of accurate diagnosis for effective patient management, preventing further transmission. Providing a clearer picture of the outbreak's scope.